English

ILEX ONCOLOGY INC

EDGAR

Quarterly report (10-Q) · filed 2004-11-09

36 filing records in this dataset, filed from 1997-05-15 to 2004-11-09. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

7.27 million USD

2004-09-30 · USD

Exact inputs and evidence

Revenue: 7271000 USD Source

Operating margin

-174.47%

2004-09-30 · %

Exact inputs and evidence

Operating Income: -12686000 USD Source
Revenue: 7271000 USD Source

Operating cash flow

-14.3 million USD

2004-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -51008000 USD Source
Operating Cash Flow: -36663000 USD Source

Free cash flow

-14.5 million USD

2004-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -51008000 USD Source
Operating Cash Flow: -36663000 USD Source
Capital Expenditure: 317000 USD Source
Capital Expenditure: 194000 USD Source

Cash and cash equivalents: 68.9 million USD 2004-09-30 Source
Exact value

68926000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

32.6 million USD

2003-10-01 – 2004-09-30

Exact inputs and evidence

Revenue: 34789000 USD · 2003-01-01 – 2003-12-31 Source
Revenue: 27537000 USD · 2003-01-01 – 2003-09-30 Source
Revenue: 10100000 USD · 2004-01-01 – 2004-03-31 Source
Revenue: 8013000 USD · 2004-04-01 – 2004-06-30 Source
Revenue: 7271000 USD · 2004-07-01 – 2004-09-30 Source

Net income

-64.5 million USD

2003-10-01 – 2004-09-30

Exact inputs and evidence

Net income: -62114000 USD · 2003-01-01 – 2003-12-31 Source
Net income: -44337000 USD · 2003-01-01 – 2003-09-30 Source
Net income: -18409000 USD · 2004-01-01 – 2004-03-31 Source
Net income: -15820000 USD · 2004-04-01 – 2004-06-30 Source
Net income: -12517000 USD · 2004-07-01 – 2004-09-30 Source

Operating cash flow

-64.7 million USD

2003-10-01 – 2004-09-30

Exact inputs and evidence

Operating cash flow: -53302000 USD · 2003-01-01 – 2003-12-31 Source
Operating cash flow: -39588000 USD · 2003-01-01 – 2003-09-30 Source
Operating cash flow: -21267000 USD · 2004-01-01 – 2004-03-31 Source
Operating cash flow: -36663000 USD · 2004-01-01 – 2004-06-30 Source
Operating cash flow: -21267000 USD · 2004-01-01 – 2004-03-31 Source
Operating cash flow: -51008000 USD · 2004-01-01 – 2004-09-30 Source
Operating cash flow: -36663000 USD · 2004-01-01 – 2004-06-30 Source

Capital expenditure

401 thousand USD

2003-10-01 – 2004-09-30

Exact inputs and evidence

Capital expenditure: 1284000 USD · 2003-01-01 – 2003-12-31 Source
Capital expenditure: 1200000 USD · 2003-01-01 – 2003-09-30 Source
Capital expenditure: 126000 USD · 2004-01-01 – 2004-03-31 Source
Capital expenditure: 194000 USD · 2004-01-01 – 2004-06-30 Source
Capital expenditure: 126000 USD · 2004-01-01 – 2004-03-31 Source
Capital expenditure: 317000 USD · 2004-01-01 – 2004-09-30 Source
Capital expenditure: 194000 USD · 2004-01-01 – 2004-06-30 Source

Free cash flow

-65.1 million USD

2003-10-01 – 2004-09-30

Exact inputs and evidence

Operating cash flow: -53302000 USD · 2003-01-01 – 2003-12-31 Source
Operating cash flow: -39588000 USD · 2003-01-01 – 2003-09-30 Source
Operating cash flow: -21267000 USD · 2004-01-01 – 2004-03-31 Source
Operating cash flow: -36663000 USD · 2004-01-01 – 2004-06-30 Source
Operating cash flow: -21267000 USD · 2004-01-01 – 2004-03-31 Source
Operating cash flow: -51008000 USD · 2004-01-01 – 2004-09-30 Source
Operating cash flow: -36663000 USD · 2004-01-01 – 2004-06-30 Source
Capital expenditure: 1284000 USD · 2003-01-01 – 2003-12-31 Source
Capital expenditure: 1200000 USD · 2003-01-01 – 2003-09-30 Source
Capital expenditure: 126000 USD · 2004-01-01 – 2004-03-31 Source
Capital expenditure: 194000 USD · 2004-01-01 – 2004-06-30 Source
Capital expenditure: 126000 USD · 2004-01-01 – 2004-03-31 Source
Capital expenditure: 317000 USD · 2004-01-01 – 2004-09-30 Source
Capital expenditure: 194000 USD · 2004-01-01 – 2004-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2004-11-09.

Financial data available through: 2003-12-31.

Coverage by financial measure

Revenue: 9 of 11 periods available· newest 2003-12-31
Operating income: 9 of 11 periods available· newest 2003-12-31
Net income: 9 of 11 periods available· newest 2003-12-31
Operating cash flow: 9 of 11 periods available· newest 2003-12-31
Capital expenditure: 9 of 11 periods available· newest 2003-12-31
Total assets: 8 of 11 periods available· newest 2003-12-31
Total liabilities: 4 of 11 periods available· newest 2003-12-31
Current assets: 8 of 11 periods available· newest 2003-12-31
Current liabilities: 8 of 11 periods available· newest 2003-12-31
Cash and cash equivalents: 9 of 11 periods available· newest 2003-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+12.6%

Prior period

USD 30.9 million

2002-01-01 – 2002-12-31
Current period

USD 34.79 million

2003-01-01 – 2003-12-31

Exact inputs and evidence

34789000 − 30901000 = 3888000 USD

30901000 USD · 2002-01-01 – 2002-12-31
Inspect prior input Prior source
34789000 USD · 2003-01-01 – 2003-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · ILEX ONCOLOGY INC · 2003-12-31 ILEX ONCOLOGY INC (edgar:1001915) Year-over-year change in Revenue: 3888000 USD Concept: fundies:Revenue Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001915?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 34789000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-04-006457.txt#4577 Input fundies:Revenue: 30901000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-04-006457.txt#4577
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 15.96 million

Prior period

−USD 46.16 million

2002-01-01 – 2002-12-31
Current period

−USD 62.11 million

2003-01-01 – 2003-12-31

Exact inputs and evidence

-62114000 − -46156000 = -15958000 USD

-46156000 USD · 2002-01-01 – 2002-12-31
Inspect prior input Prior source
-62114000 USD · 2003-01-01 – 2003-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · ILEX ONCOLOGY INC · 2003-12-31 ILEX ONCOLOGY INC (edgar:1001915) Year-over-year change in Net income: -15958000 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001915?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -62114000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-04-006457.txt#6640 Input fundies:NetIncome: -46156000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-04-006457.txt#6640
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 2.66 million

Prior period

−USD 50.64 million

2002-01-01 – 2002-12-31
Current period

−USD 53.3 million

2003-01-01 – 2003-12-31

Exact inputs and evidence

-53302000 − -50643000 = -2659000 USD

-50643000 USD · 2002-01-01 – 2002-12-31
Inspect prior input Prior source
-53302000 USD · 2003-01-01 – 2003-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · ILEX ONCOLOGY INC · 2003-12-31 ILEX ONCOLOGY INC (edgar:1001915) Year-over-year change in Operating cash flow: -2659000 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001915?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -53302000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-04-006457.txt#6975 Input fundies:OperatingCashFlow: -50643000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-04-006457.txt#6975
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-23.6%

Prior period

USD 1.68 million

2002-01-01 – 2002-12-31
Current period

USD 1.28 million

2003-01-01 – 2003-12-31

Exact inputs and evidence

1284000 − 1680000 = -396000 USD

1680000 USD · 2002-01-01 – 2002-12-31
Inspect prior input Prior source
1284000 USD · 2003-01-01 – 2003-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · ILEX ONCOLOGY INC · 2003-12-31 ILEX ONCOLOGY INC (edgar:1001915) Year-over-year change in Capital expenditure: -396000 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001915?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 1284000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-04-006457.txt#7052 Input fundies:CapitalExpenditure: 1680000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-04-006457.txt#7052
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2003 2003-01-01 – 2003-12-31

Revenue USD 34.79 million 100% of revenue
Operating costs Derived USD 97.06 million 279% of revenue
Operating income −USD 62.28 million −179% of revenue
Tax, interest and other Derived −USD 161,000 −0.5% of revenue
Net income −USD 62.11 million −179% of revenue

Cash

Operating cash flow −USD 53.3 million −153% of revenue
Capital expenditure USD 1.28 million 3.7% of revenue
Free cash flow Derived −USD 54.59 million −157% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1995 Operating loss: operating costs were 120% of revenue.
1996 Operating loss: operating costs were 107% of revenue.
1997 Operating loss: operating costs were 160% of revenue.
1998 Operating loss: operating costs were 220% of revenue.
1999 Operating loss: operating costs were 323% of revenue.
2000 Operating loss: operating costs were 237% of revenue.
2001 Operating loss: operating costs were 559% of revenue.
2002 Operating loss: operating costs were 250% of revenue.
2003 Operating loss: operating costs were 279% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1995 1995-01-01 – 1995-12-31	4209000	5054000 Derived	-845000	-133000 Derived	-712000	-878000 Derived	Source 1995-01-01 – 1995-12-31: 4209000 USD Inspect Revenue Open source 1995-01-01 – 1995-12-31: -845000 USD Inspect Operating Income Open source 1995-01-01 – 1995-12-31: -712000 USD Inspect Net Income Open source 1995-01-01 – 1995-12-31: -410000 USD Inspect Operating Cash Flow Open source 1995-01-01 – 1995-12-31: 468000 USD Inspect Capital Expenditure Open source
1996 1996-01-01 – 1996-12-31	8143000	8692000 Derived	-549000	66000 Derived	-615000	-1277000 Derived	Source 1996-01-01 – 1996-12-31: 8143000 USD Inspect Revenue Open source 1996-01-01 – 1996-12-31: -549000 USD Inspect Operating Income Open source 1996-01-01 – 1996-12-31: -615000 USD Inspect Net Income Open source 1996-01-01 – 1996-12-31: -738000 USD Inspect Operating Cash Flow Open source 1996-01-01 – 1996-12-31: 539000 USD Inspect Capital Expenditure Open source
1997 1997-01-01 – 1997-12-31	11230000	18018000 Derived	-6788000	1894000 Derived	-8682000	-6871000 Derived	Source 1997-01-01 – 1997-12-31: 11230000 USD Inspect Revenue Open source 1997-01-01 – 1997-12-31: -6788000 USD Inspect Operating Income Open source 1997-01-01 – 1997-12-31: -8682000 USD Inspect Net Income Open source 1997-01-01 – 1997-12-31: -4824000 USD Inspect Operating Cash Flow Open source 1997-01-01 – 1997-12-31: 2047000 USD Inspect Capital Expenditure Open source
1998 1998-01-01 – 1998-12-31	14272000	31356000 Derived	-17084000	4144000 Derived	-21228000	-16425000 Derived	Source 1998-01-01 – 1998-12-31: 14272000 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: -17084000 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: -21228000 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: -13717000 USD Inspect Operating Cash Flow Open source 1998-01-01 – 1998-12-31: 2708000 USD Inspect Capital Expenditure Open source
1999 1999-01-01 – 1999-12-31	18103000	58525000 Derived	-40422000	5633000 Derived	-46055000	-17507000 Derived	Source 1999-01-01 – 1999-12-31: 18103000 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: -40422000 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: -46055000 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: -15784000 USD Inspect Operating Cash Flow Open source 1999-01-01 – 1999-12-31: 1723000 USD Inspect Capital Expenditure Open source
2000 2000-01-01 – 2000-12-31	32788000	77788000 Derived	-45000000	-6018000 Derived	-38982000	-15222000 Derived	Source 2000-01-01 – 2000-12-31: 32788000 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: -45000000 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: -38982000 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: -11209000 USD Inspect Operating Cash Flow Open source 2000-01-01 – 2000-12-31: 4013000 USD Inspect Capital Expenditure Open source
2001 2001-01-01 – 2001-12-31	29172000	163193000 Derived	-134021000	-13067000 Derived	-120954000	-29647000 Derived	Source 2001-01-01 – 2001-12-31: 29172000 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -134021000 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: -120954000 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: -27655000 USD Inspect Operating Cash Flow Open source 2001-01-01 – 2001-12-31: 1992000 USD Inspect Capital Expenditure Open source
2002 2002-01-01 – 2002-12-31	30901000	77198000 Derived	-46297000	-141000 Derived	-46156000	-52323000 Derived	Source 2002-01-01 – 2002-12-31: 30901000 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -46297000 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: -46156000 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: -50643000 USD Inspect Operating Cash Flow Open source 2002-01-01 – 2002-12-31: 1680000 USD Inspect Capital Expenditure Open source
2003 2003-01-01 – 2003-12-31	34789000	97064000 Derived	-62275000	-161000 Derived	-62114000	-54586000 Derived	Source 2003-01-01 – 2003-12-31: 34789000 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -62275000 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -62114000 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -53302000 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 1284000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 34.8M 2003

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19951995-12-31	Revenue	4209000	Revenue: 4209000 Open source
19961996-12-31	Revenue	8143000	Revenue: 8143000 Open source
19971997-12-31	Revenue	11230000	Revenue: 11230000 Open source
19981998-12-31	Revenue	14272000	Revenue: 14272000 Open source
19991999-12-31	Revenue	18103000	Revenue: 18103000 Open source
20002000-12-31	Revenue	32788000	Revenue: 32788000 Open source
20012001-12-31	Revenue	29172000	Revenue: 29172000 Open source
20022002-12-31	Revenue	30901000	Revenue: 30901000 Open source
20032003-12-31	Revenue	34789000	Revenue: 34789000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

12.6% 2003

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19951995-12-31	Year over year	No prior comparable period	Revenue: 4209000 Open source
19961996-12-31	Year over year	93.5%	Revenue: 8143000 Open source Revenue: 4209000 Open source
19971997-12-31	Year over year	37.9%	Revenue: 11230000 Open source Revenue: 8143000 Open source
19981998-12-31	Year over year	27.1%	Revenue: 14272000 Open source Revenue: 11230000 Open source
19991999-12-31	Year over year	26.8%	Revenue: 18103000 Open source Revenue: 14272000 Open source
20002000-12-31	Year over year	81.1%	Revenue: 32788000 Open source Revenue: 18103000 Open source
20012001-12-31	Year over year	-11%	Revenue: 29172000 Open source Revenue: 32788000 Open source
20022002-12-31	Year over year	5.9%	Revenue: 30901000 Open source Revenue: 29172000 Open source
20032003-12-31	Year over year	12.6%	Revenue: 34789000 Open source Revenue: 30901000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -179% 2003

Net margin -178.5% 2003

Free cash flow margin -156.9% 2003

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19951995-12-31	Operating margin	-20.1%	Operating Income: -845000 Open source Revenue: 4209000 Open source
19961996-12-31	Operating margin	-6.7%	Operating Income: -549000 Open source Revenue: 8143000 Open source
19971997-12-31	Operating margin	-60.4%	Operating Income: -6788000 Open source Revenue: 11230000 Open source
19981998-12-31	Operating margin	-119.7%	Operating Income: -17084000 Open source Revenue: 14272000 Open source
19991999-12-31	Operating margin	-223.3%	Operating Income: -40422000 Open source Revenue: 18103000 Open source
20002000-12-31	Operating margin	-137.2%	Operating Income: -45000000 Open source Revenue: 32788000 Open source
20012001-12-31	Operating margin	-459.4%	Operating Income: -134021000 Open source Revenue: 29172000 Open source
20022002-12-31	Operating margin	-149.8%	Operating Income: -46297000 Open source Revenue: 30901000 Open source
20032003-12-31	Operating margin	-179%	Operating Income: -62275000 Open source Revenue: 34789000 Open source
19951995-12-31	Net margin	-16.9%	Net Income: -712000 Open source Revenue: 4209000 Open source
19961996-12-31	Net margin	-7.6%	Net Income: -615000 Open source Revenue: 8143000 Open source
19971997-12-31	Net margin	-77.3%	Net Income: -8682000 Open source Revenue: 11230000 Open source
19981998-12-31	Net margin	-148.7%	Net Income: -21228000 Open source Revenue: 14272000 Open source
19991999-12-31	Net margin	-254.4%	Net Income: -46055000 Open source Revenue: 18103000 Open source
20002000-12-31	Net margin	-118.9%	Net Income: -38982000 Open source Revenue: 32788000 Open source
20012001-12-31	Net margin	-414.6%	Net Income: -120954000 Open source Revenue: 29172000 Open source
20022002-12-31	Net margin	-149.4%	Net Income: -46156000 Open source Revenue: 30901000 Open source
20032003-12-31	Net margin	-178.5%	Net Income: -62114000 Open source Revenue: 34789000 Open source
19951995-12-31	Free cash flow margin	-20.9%	Revenue: 4209000 Open source Operating Cash Flow: -410000 Open source Capital Expenditure: 468000 Open source
19961996-12-31	Free cash flow margin	-15.7%	Revenue: 8143000 Open source Operating Cash Flow: -738000 Open source Capital Expenditure: 539000 Open source
19971997-12-31	Free cash flow margin	-61.2%	Revenue: 11230000 Open source Operating Cash Flow: -4824000 Open source Capital Expenditure: 2047000 Open source
19981998-12-31	Free cash flow margin	-115.1%	Revenue: 14272000 Open source Operating Cash Flow: -13717000 Open source Capital Expenditure: 2708000 Open source
19991999-12-31	Free cash flow margin	-96.7%	Revenue: 18103000 Open source Operating Cash Flow: -15784000 Open source Capital Expenditure: 1723000 Open source
20002000-12-31	Free cash flow margin	-46.4%	Revenue: 32788000 Open source Operating Cash Flow: -11209000 Open source Capital Expenditure: 4013000 Open source
20012001-12-31	Free cash flow margin	-101.6%	Revenue: 29172000 Open source Operating Cash Flow: -27655000 Open source Capital Expenditure: 1992000 Open source
20022002-12-31	Free cash flow margin	-169.3%	Revenue: 30901000 Open source Operating Cash Flow: -50643000 Open source Capital Expenditure: 1680000 Open source
20032003-12-31	Free cash flow margin	-156.9%	Revenue: 34789000 Open source Operating Cash Flow: -53302000 Open source Capital Expenditure: 1284000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -53.3M 2003

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19951995-12-31	Operating cash flow	-410000	Operating Cash Flow: -410000 Open source
19961996-12-31	Operating cash flow	-738000	Operating Cash Flow: -738000 Open source
19971997-12-31	Operating cash flow	-4824000	Operating Cash Flow: -4824000 Open source
19981998-12-31	Operating cash flow	-13717000	Operating Cash Flow: -13717000 Open source
19991999-12-31	Operating cash flow	-15784000	Operating Cash Flow: -15784000 Open source
20002000-12-31	Operating cash flow	-11209000	Operating Cash Flow: -11209000 Open source
20012001-12-31	Operating cash flow	-27655000	Operating Cash Flow: -27655000 Open source
20022002-12-31	Operating cash flow	-50643000	Operating Cash Flow: -50643000 Open source
20032003-12-31	Operating cash flow	-53302000	Operating Cash Flow: -53302000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -54.6M 2003

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19951995-12-31	Free cash flow	-878000	Operating Cash Flow: -410000 Open source Capital Expenditure: 468000 Open source
19961996-12-31	Free cash flow	-1277000	Operating Cash Flow: -738000 Open source Capital Expenditure: 539000 Open source
19971997-12-31	Free cash flow	-6871000	Operating Cash Flow: -4824000 Open source Capital Expenditure: 2047000 Open source
19981998-12-31	Free cash flow	-16425000	Operating Cash Flow: -13717000 Open source Capital Expenditure: 2708000 Open source
19991999-12-31	Free cash flow	-17507000	Operating Cash Flow: -15784000 Open source Capital Expenditure: 1723000 Open source
20002000-12-31	Free cash flow	-15222000	Operating Cash Flow: -11209000 Open source Capital Expenditure: 4013000 Open source
20012001-12-31	Free cash flow	-29647000	Operating Cash Flow: -27655000 Open source Capital Expenditure: 1992000 Open source
20022002-12-31	Free cash flow	-52323000	Operating Cash Flow: -50643000 Open source Capital Expenditure: 1680000 Open source
20032003-12-31	Free cash flow	-54586000	Operating Cash Flow: -53302000 Open source Capital Expenditure: 1284000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

21.5% 2003

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1995-12-31	Liabilities / assets	Not reported	No source recorded
1996-12-31	Liabilities / assets	Not reported	Total Assets: 27374000 Open source
1997-12-31	Liabilities / assets	Not reported	Total Assets: 55311000 Open source
1998-12-31	Liabilities / assets	Not reported	Total Assets: 42688000 Open source
1999-12-31	Liabilities / assets	Not reported	Total Assets: 100706000 Open source
20002000-12-31	Liabilities / assets	9.4%	Total Liabilities: 20351000 Open source Total Assets: 216356000 Open source
20012001-12-31	Liabilities / assets	40.1%	Total Liabilities: 147879000 Open source Total Assets: 368907000 Open source
20022002-12-31	Liabilities / assets	34.6%	Total Liabilities: 93664000 Open source Total Assets: 270906000 Open source
20032003-12-31	Liabilities / assets	21.5%	Total Liabilities: 59281000 Open source Total Assets: 275095000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.66× 2003

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
1995-12-31	Current assets / current liabilities	Not reported	No source recorded
19961996-12-31	Current assets / current liabilities	6.03×	Current Assets: 14004000 Open source Current Liabilities: 2322000 Open source
19971997-12-31	Current assets / current liabilities	9.7×	Current Assets: 36891000 Open source Current Liabilities: 3802000 Open source
19981998-12-31	Current assets / current liabilities	4.75×	Current Assets: 30322000 Open source Current Liabilities: 6380000 Open source
19991999-12-31	Current assets / current liabilities	8.23×	Current Assets: 87902000 Open source Current Liabilities: 10676000 Open source
20002000-12-31	Current assets / current liabilities	9.65×	Current Assets: 170611000 Open source Current Liabilities: 17689000 Open source
20012001-12-31	Current assets / current liabilities	2.46×	Current Assets: 177079000 Open source Current Liabilities: 72113000 Open source
20022002-12-31	Current assets / current liabilities	2.92×	Current Assets: 165745000 Open source Current Liabilities: 56738000 Open source
20032003-12-31	Current assets / current liabilities	2.66×	Current Assets: 152875000 Open source Current Liabilities: 57462000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1995 1995-01-01 – 1995-12-31	−USD 712,000 Exact value Exact value: -712000 USD 1995-01-01 – 1995-12-31: -712000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ILEX ONCOLOGY INC · 1995-12-31 ILEX ONCOLOGY INC (edgar:1001915) Net Income: -712000 USD Concept: fundies:NetIncome Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001915/explain?concept=fundies%3ANetIncome&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:NetIncome: -712000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-98-002695.txt#4488 The citation records this snapshot. The page link may show a newer release later.	−USD 410,000 Exact value Exact value: -410000 USD 1995-01-01 – 1995-12-31: -410000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ILEX ONCOLOGY INC · 1995-12-31 ILEX ONCOLOGY INC (edgar:1001915) Operating Cash Flow: -410000 USD Concept: fundies:OperatingCashFlow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001915/explain?concept=fundies%3AOperatingCashFlow&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -410000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-98-002695.txt#4506 The citation records this snapshot. The page link may show a newer release later.	USD 468,000 Exact value Exact value: 468000 USD 1995-01-01 – 1995-12-31: 468000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ILEX ONCOLOGY INC · 1995-12-31 ILEX ONCOLOGY INC (edgar:1001915) Capital Expenditure: 468000 USD Concept: fundies:CapitalExpenditure Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001915/explain?concept=fundies%3ACapitalExpenditure&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 468000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-98-002695.txt#4512 The citation records this snapshot. The page link may show a newer release later.	−USD 878,000 Calculation and evidence -410000 − 468000 USD Exact free cash flow: -878000 USD 1995-01-01 – 1995-12-31: -410000 USD · Inspect Operating Cash Flow · Source 1995-01-01 – 1995-12-31: 468000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ILEX ONCOLOGY INC · 1995-12-31 ILEX ONCOLOGY INC (edgar:1001915) Free cash flow: -878000 USD Concept: free-cash-flow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001915?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -410000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-98-002695.txt#4506 Input fundies:CapitalExpenditure: 468000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-98-002695.txt#4512 The citation records this snapshot. The page link may show a newer release later.
1996 1996-01-01 – 1996-12-31	−USD 615,000 Exact value Exact value: -615000 USD 1996-01-01 – 1996-12-31: -615000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ILEX ONCOLOGY INC · 1996-12-31 ILEX ONCOLOGY INC (edgar:1001915) Net Income: -615000 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001915/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: -615000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950129-99-001286.txt#4276 The citation records this snapshot. The page link may show a newer release later.	−USD 738,000 Exact value Exact value: -738000 USD 1996-01-01 – 1996-12-31: -738000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ILEX ONCOLOGY INC · 1996-12-31 ILEX ONCOLOGY INC (edgar:1001915) Operating Cash Flow: -738000 USD Concept: fundies:OperatingCashFlow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001915/explain?concept=fundies%3AOperatingCashFlow&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -738000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950129-99-001286.txt#4295 The citation records this snapshot. The page link may show a newer release later.	USD 539,000 Exact value Exact value: 539000 USD 1996-01-01 – 1996-12-31: 539000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ILEX ONCOLOGY INC · 1996-12-31 ILEX ONCOLOGY INC (edgar:1001915) Capital Expenditure: 539000 USD Concept: fundies:CapitalExpenditure Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001915/explain?concept=fundies%3ACapitalExpenditure&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 539000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950129-99-001286.txt#4300 The citation records this snapshot. The page link may show a newer release later.	−USD 1.28 million Calculation and evidence -738000 − 539000 USD Exact free cash flow: -1277000 USD 1996-01-01 – 1996-12-31: -738000 USD · Inspect Operating Cash Flow · Source 1996-01-01 – 1996-12-31: 539000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ILEX ONCOLOGY INC · 1996-12-31 ILEX ONCOLOGY INC (edgar:1001915) Free cash flow: -1277000 USD Concept: free-cash-flow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001915?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -738000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950129-99-001286.txt#4295 Input fundies:CapitalExpenditure: 539000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950129-99-001286.txt#4300 The citation records this snapshot. The page link may show a newer release later.
1997 1997-01-01 – 1997-12-31	−USD 8.68 million Exact value Exact value: -8682000 USD 1997-01-01 – 1997-12-31: -8682000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ILEX ONCOLOGY INC · 1997-12-31 ILEX ONCOLOGY INC (edgar:1001915) Net Income: -8682000 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001915/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8682000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-00-003150.txt#1054 The citation records this snapshot. The page link may show a newer release later.	−USD 4.82 million Exact value Exact value: -4824000 USD 1997-01-01 – 1997-12-31: -4824000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ILEX ONCOLOGY INC · 1997-12-31 ILEX ONCOLOGY INC (edgar:1001915) Operating Cash Flow: -4824000 USD Concept: fundies:OperatingCashFlow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001915/explain?concept=fundies%3AOperatingCashFlow&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4824000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-00-003150.txt#1074 The citation records this snapshot. The page link may show a newer release later.	USD 2.05 million Exact value Exact value: 2047000 USD 1997-01-01 – 1997-12-31: 2047000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ILEX ONCOLOGY INC · 1997-12-31 ILEX ONCOLOGY INC (edgar:1001915) Capital Expenditure: 2047000 USD Concept: fundies:CapitalExpenditure Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001915/explain?concept=fundies%3ACapitalExpenditure&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2047000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-00-003150.txt#1080 The citation records this snapshot. The page link may show a newer release later.	−USD 6.87 million Calculation and evidence -4824000 − 2047000 USD Exact free cash flow: -6871000 USD 1997-01-01 – 1997-12-31: -4824000 USD · Inspect Operating Cash Flow · Source 1997-01-01 – 1997-12-31: 2047000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ILEX ONCOLOGY INC · 1997-12-31 ILEX ONCOLOGY INC (edgar:1001915) Free cash flow: -6871000 USD Concept: free-cash-flow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001915?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4824000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-00-003150.txt#1074 Input fundies:CapitalExpenditure: 2047000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-00-003150.txt#1080 The citation records this snapshot. The page link may show a newer release later.
1998 1998-01-01 – 1998-12-31	−USD 21.23 million Exact value Exact value: -21228000 USD 1998-01-01 – 1998-12-31: -21228000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ILEX ONCOLOGY INC · 1998-12-31 ILEX ONCOLOGY INC (edgar:1001915) Net Income: -21228000 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001915/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: -21228000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-01-003052.txt#3617 The citation records this snapshot. The page link may show a newer release later.	−USD 13.72 million Exact value Exact value: -13717000 USD 1998-01-01 – 1998-12-31: -13717000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ILEX ONCOLOGY INC · 1998-12-31 ILEX ONCOLOGY INC (edgar:1001915) Operating Cash Flow: -13717000 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001915/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13717000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-01-003052.txt#3640 The citation records this snapshot. The page link may show a newer release later.	USD 2.71 million Exact value Exact value: 2708000 USD 1998-01-01 – 1998-12-31: 2708000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ILEX ONCOLOGY INC · 1998-12-31 ILEX ONCOLOGY INC (edgar:1001915) Capital Expenditure: 2708000 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001915/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2708000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-01-003052.txt#3646 The citation records this snapshot. The page link may show a newer release later.	−USD 16.43 million Calculation and evidence -13717000 − 2708000 USD Exact free cash flow: -16425000 USD 1998-01-01 – 1998-12-31: -13717000 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 2708000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ILEX ONCOLOGY INC · 1998-12-31 ILEX ONCOLOGY INC (edgar:1001915) Free cash flow: -16425000 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001915?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13717000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-01-003052.txt#3640 Input fundies:CapitalExpenditure: 2708000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-01-003052.txt#3646 The citation records this snapshot. The page link may show a newer release later.
1999 1999-01-01 – 1999-12-31	−USD 46.06 million Exact value Exact value: -46055000 USD 1999-01-01 – 1999-12-31: -46055000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ILEX ONCOLOGY INC · 1999-12-31 ILEX ONCOLOGY INC (edgar:1001915) Net Income: -46055000 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001915/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -46055000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-02-002112.txt#3408 The citation records this snapshot. The page link may show a newer release later.	−USD 15.78 million Exact value Exact value: -15784000 USD 1999-01-01 – 1999-12-31: -15784000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ILEX ONCOLOGY INC · 1999-12-31 ILEX ONCOLOGY INC (edgar:1001915) Operating Cash Flow: -15784000 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001915/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15784000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-02-002112.txt#3432 The citation records this snapshot. The page link may show a newer release later.	USD 1.72 million Exact value Exact value: 1723000 USD 1999-01-01 – 1999-12-31: 1723000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ILEX ONCOLOGY INC · 1999-12-31 ILEX ONCOLOGY INC (edgar:1001915) Capital Expenditure: 1723000 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001915/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1723000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-02-002112.txt#3438 The citation records this snapshot. The page link may show a newer release later.	−USD 17.51 million Calculation and evidence -15784000 − 1723000 USD Exact free cash flow: -17507000 USD 1999-01-01 – 1999-12-31: -15784000 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 1723000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ILEX ONCOLOGY INC · 1999-12-31 ILEX ONCOLOGY INC (edgar:1001915) Free cash flow: -17507000 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001915?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -15784000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-02-002112.txt#3432 Input fundies:CapitalExpenditure: 1723000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-02-002112.txt#3438 The citation records this snapshot. The page link may show a newer release later.
2000 2000-01-01 – 2000-12-31	−USD 38.98 million Exact value Exact value: -38982000 USD 2000-01-01 – 2000-12-31: -38982000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ILEX ONCOLOGY INC · 2000-12-31 ILEX ONCOLOGY INC (edgar:1001915) Net Income: -38982000 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001915/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -38982000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-03-003987.txt#9401 The citation records this snapshot. The page link may show a newer release later.	−USD 11.21 million Exact value Exact value: -11209000 USD 2000-01-01 – 2000-12-31: -11209000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ILEX ONCOLOGY INC · 2000-12-31 ILEX ONCOLOGY INC (edgar:1001915) Operating Cash Flow: -11209000 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001915/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -11209000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-03-003987.txt#9832 The citation records this snapshot. The page link may show a newer release later.	USD 4.01 million Exact value Exact value: 4013000 USD 2000-01-01 – 2000-12-31: 4013000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ILEX ONCOLOGY INC · 2000-12-31 ILEX ONCOLOGY INC (edgar:1001915) Capital Expenditure: 4013000 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001915/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4013000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-03-003987.txt#9916 The citation records this snapshot. The page link may show a newer release later.	−USD 15.22 million Calculation and evidence -11209000 − 4013000 USD Exact free cash flow: -15222000 USD 2000-01-01 – 2000-12-31: -11209000 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 4013000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ILEX ONCOLOGY INC · 2000-12-31 ILEX ONCOLOGY INC (edgar:1001915) Free cash flow: -15222000 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001915?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -11209000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-03-003987.txt#9832 Input fundies:CapitalExpenditure: 4013000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-03-003987.txt#9916 The citation records this snapshot. The page link may show a newer release later.
2001 2001-01-01 – 2001-12-31	−USD 120.95 million Exact value Exact value: -120954000 USD 2001-01-01 – 2001-12-31: -120954000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ILEX ONCOLOGY INC · 2001-12-31 ILEX ONCOLOGY INC (edgar:1001915) Net Income: -120954000 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001915/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -120954000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-04-006457.txt#6640 The citation records this snapshot. The page link may show a newer release later.	−USD 27.66 million Exact value Exact value: -27655000 USD 2001-01-01 – 2001-12-31: -27655000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ILEX ONCOLOGY INC · 2001-12-31 ILEX ONCOLOGY INC (edgar:1001915) Operating Cash Flow: -27655000 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001915/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -27655000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-04-006457.txt#6975 The citation records this snapshot. The page link may show a newer release later.	USD 1.99 million Exact value Exact value: 1992000 USD 2001-01-01 – 2001-12-31: 1992000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ILEX ONCOLOGY INC · 2001-12-31 ILEX ONCOLOGY INC (edgar:1001915) Capital Expenditure: 1992000 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001915/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1992000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-04-006457.txt#7052 The citation records this snapshot. The page link may show a newer release later.	−USD 29.65 million Calculation and evidence -27655000 − 1992000 USD Exact free cash flow: -29647000 USD 2001-01-01 – 2001-12-31: -27655000 USD · Inspect Operating Cash Flow · Source 2001-01-01 – 2001-12-31: 1992000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ILEX ONCOLOGY INC · 2001-12-31 ILEX ONCOLOGY INC (edgar:1001915) Free cash flow: -29647000 USD Concept: free-cash-flow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001915?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -27655000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-04-006457.txt#6975 Input fundies:CapitalExpenditure: 1992000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-04-006457.txt#7052 The citation records this snapshot. The page link may show a newer release later.
2002 2002-01-01 – 2002-12-31	−USD 46.16 million Exact value Exact value: -46156000 USD 2002-01-01 – 2002-12-31: -46156000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ILEX ONCOLOGY INC · 2002-12-31 ILEX ONCOLOGY INC (edgar:1001915) Net Income: -46156000 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001915/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -46156000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-04-006457.txt#6640 The citation records this snapshot. The page link may show a newer release later.	−USD 50.64 million Exact value Exact value: -50643000 USD 2002-01-01 – 2002-12-31: -50643000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ILEX ONCOLOGY INC · 2002-12-31 ILEX ONCOLOGY INC (edgar:1001915) Operating Cash Flow: -50643000 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001915/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -50643000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-04-006457.txt#6975 The citation records this snapshot. The page link may show a newer release later.	USD 1.68 million Exact value Exact value: 1680000 USD 2002-01-01 – 2002-12-31: 1680000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ILEX ONCOLOGY INC · 2002-12-31 ILEX ONCOLOGY INC (edgar:1001915) Capital Expenditure: 1680000 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001915/explain?concept=fundies%3ACapitalExpenditure&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1680000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-04-006457.txt#7052 The citation records this snapshot. The page link may show a newer release later.	−USD 52.32 million Calculation and evidence -50643000 − 1680000 USD Exact free cash flow: -52323000 USD 2002-01-01 – 2002-12-31: -50643000 USD · Inspect Operating Cash Flow · Source 2002-01-01 – 2002-12-31: 1680000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ILEX ONCOLOGY INC · 2002-12-31 ILEX ONCOLOGY INC (edgar:1001915) Free cash flow: -52323000 USD Concept: free-cash-flow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001915?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -50643000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-04-006457.txt#6975 Input fundies:CapitalExpenditure: 1680000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-04-006457.txt#7052 The citation records this snapshot. The page link may show a newer release later.
2003 2003-01-01 – 2003-12-31	−USD 62.11 million Exact value Exact value: -62114000 USD 2003-01-01 – 2003-12-31: -62114000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ILEX ONCOLOGY INC · 2003-12-31 ILEX ONCOLOGY INC (edgar:1001915) Net Income: -62114000 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001915/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -62114000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-04-006457.txt#6640 The citation records this snapshot. The page link may show a newer release later.	−USD 53.3 million Exact value Exact value: -53302000 USD 2003-01-01 – 2003-12-31: -53302000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ILEX ONCOLOGY INC · 2003-12-31 ILEX ONCOLOGY INC (edgar:1001915) Operating Cash Flow: -53302000 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001915/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -53302000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-04-006457.txt#6975 The citation records this snapshot. The page link may show a newer release later.	USD 1.28 million Exact value Exact value: 1284000 USD 2003-01-01 – 2003-12-31: 1284000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ILEX ONCOLOGY INC · 2003-12-31 ILEX ONCOLOGY INC (edgar:1001915) Capital Expenditure: 1284000 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001915/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1284000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-04-006457.txt#7052 The citation records this snapshot. The page link may show a newer release later.	−USD 54.59 million Calculation and evidence -53302000 − 1284000 USD Exact free cash flow: -54586000 USD 2003-01-01 – 2003-12-31: -53302000 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 1284000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ILEX ONCOLOGY INC · 2003-12-31 ILEX ONCOLOGY INC (edgar:1001915) Free cash flow: -54586000 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001915?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -53302000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-04-006457.txt#6975 Input fundies:CapitalExpenditure: 1284000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001915/0000950134-04-006457.txt#7052 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

36 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001001915, 1001915, edgar:1001915

ILEX ONCOLOGY INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2003 2003-01-01 – 2003-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation